Benchmarks come off day's high; pharma shares advance

Image
Capital Market
Last Updated : Apr 08 2021 | 2:50 PM IST

The key equity indices came off the day's high in mid-afternoon trade. At 14:23 IST, the barometer index, the S&P BSE Sensex, was up 294.65 points or 0.59% to 49,956.41. The Nifty 50 index rallied 118.40 points or 0.80% at 14,937.45. Pharma shares extended their wining streak for third day.

The broader market rallied. The S&P BSE Mid-Cap index rose 0.91%. The S&P BSE Small-Cap index added 1.05%.

Buyers outnumbered sellers. On the BSE, 1897 shares rose and 949 shares fell. A total of 162 shares were unchanged.

Investors risk appetite improved after the minutes of last month's meeting of the U.S. Federal Reserve suggested that Fed officials were united on the need to see more progress on economic recovery before scaling back their bond-buying program.

Domestic sentiment also received a boost after the Reserve Bank of India (RBI) on Wednesday kept its monetary policy accommodative to support economic growth.

Numbers To Track:

In the foreign exchange market, the partially convertible rupee rose to 74.4750 compared with its previous closing of 74.4775.

The yield on 10-year benchmark federal paper fell to 6.050% as compared to its previous close of 6.082%.

MCX Gold futures for 4 June 2021 settlement added 0.19% to Rs 46,450.

The US Dollar index (DXY), which tracks the greenback's value against a basket of currencies, shed 0.13% to 92.34.

In the commodities market, Brent crude for June 2021 settlement shed 20 cents to $62.96 a barrel. The contract gained 0.67% or 42 cents to settle at $63.16 in the previous trading session.

Buzzing Index:

The Nifty Pharma index rose 0.63% to 12,696.35, extending gains for third day. The index has added 2.96% in three sessions.

Cadila Healthcare (up 2.98%), Lupin (up 1.96%), Divi's Labs (up 1.38%), Aurobindo Pharma (up 0.80%), Cipla (up 0.78) and Dr. Reddy's Labs (up 0.69%) advanced.

Stocks in Spotlight:

Minda Corporation rose 2.14% to Rs 102.80. the company announced its partnership with Israel-based Ride Vision, a leading ADAS (rider assistance systems) solutions company, to bring its range of artificial intelligence-enabled collision avoidance technology products for the Indian two-wheeler market.

Hester Biosciences jumped 10.78% to Rs 2230. The company announced signing of agreement with ICAR-IVRI (Indian Council of Agri Research - Indian Veterinary Research Institute) for acquiring technologies for the production and commercialisation of classical swine fever vaccine & sheep pox vaccine.

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Apr 08 2021 | 2:16 PM IST

Next Story